Метод оценки Fc опосредованной эффекторных функций, вызванных гриппа гемагглютинин специфические антитела

Overview

This article describes a method for measuring the activation of Fc-mediated effector functions by antibodies targeting the influenza virus hemagglutinin. The assay can be adapted for monoclonal antibodies or polyclonal sera against other viral glycoproteins.

Key Study Components

Area of Science

• Immunology
• Vaccinology

Background

• Fc-mediated immunity plays a crucial role in the immune response.
• Understanding antibody interactions with viral proteins is essential for vaccine development.
• This method allows for rapid assessment of antibody efficacy.

Purpose of Study

• To evaluate the ability of antibodies to activate Fc-mediated effector functions.
• To provide a protocol that can be completed within 24 hours.
• To facilitate research in immunology and vaccine efficacy.

Methods Used

• Transfection of human embryonic kidney 293 cells with DNA coding for viral hemagglutinin.
• Measurement of antibody-dependent cellular cytotoxicity.
• Use of a 96-well plate format for high-throughput analysis.
• Data analysis conducted within 24 hours post-experiment.

Main Results

• The method successfully measures Fc-mediated effector functions.
• Results can be obtained quickly, enhancing research efficiency.
• Adaptable for various antibodies targeting different viral glycoproteins.

Conclusions

• This assay provides a valuable tool for assessing antibody efficacy.
• It contributes to the understanding of Fc-mediated immunity.
• The rapid turnaround time supports timely research advancements.

Frequently Asked Questions